These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10447770)

  • 1. Interleukin-12-secreting fibroblasts are more efficient than free recombinant interleukin-12 in inducing the persistent resistance to Mycobacterium avium complex infection.
    Kang BY; Chung SW; Lim YS; Kim EJ; Kim SH; Hwang SY; Kim TS
    Immunology; 1999 Jul; 97(3):474-80. PubMed ID: 10447770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of persistent in vivo resistance to Mycobacterium avium infection in BALB/c mice injected with interleukin-18-secreting fibroblasts.
    Chung SW; Choi SH; Kim TS
    Vaccine; 2004 Jan; 22(3-4):398-406. PubMed ID: 14670321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of in vivo persistent anti-mycobacterial activity by interferon-gamma-secreting fibroblasts.
    Kim TS; Chung SW; Kang BY; Choe YY; Hwang SY
    Vaccine; 2000 Jan; 18(11-12):1067-73. PubMed ID: 10590327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD3 single-chain Fv/interleukin-18 fusion DNA induces anti-mycobacterial resistance via efficient interferon-gamma production in BALB/c mice infected with Mycobacterium avium.
    Kim SH; Cho D; Kim TS
    Vaccine; 2006 Apr; 24(16):3365-73. PubMed ID: 16481075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient induction of an antigen-specific, T helper type 1 immune response by interleukin-12-secreting fibroblasts.
    Kim TS; Kim KM; Shin BA; Hwang SY
    Immunology; 2000 Jun; 100(2):203-8. PubMed ID: 10886396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of in vivo resistance to Mycobacterium avium infection by intramuscular injection with DNA encoding interleukin-18.
    Kim SH; Cho D; Kim TS
    Immunology; 2001 Feb; 102(2):234-41. PubMed ID: 11260329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous interleukin-12 is involved in resistance of mice to Mycobacterium avium complex infection.
    Saunders BM; Zhan Y; Cheers C
    Infect Immun; 1995 Oct; 63(10):4011-5. PubMed ID: 7558312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injection with interleukin-4-secreting fibroblasts efficiently induces T helper type 2 cell-dominated immune response.
    Kim TS; Kim SH; Hwang SY
    Vaccine; 2000 Jun; 18(25):2832-7. PubMed ID: 10812226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous inhibition of antimycobacterial immunity by IL-10 varies between mycobacterial species.
    Roach DR; Martin E; Bean AG; Rennick DM; Briscoe H; Britton WJ
    Scand J Immunol; 2001; 54(1-2):163-70. PubMed ID: 11439163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Th1/Th17 balance regulated by T-bet in a mouse model of Mycobacterium avium complex disease.
    Matsuyama M; Ishii Y; Yageta Y; Ohtsuka S; Ano S; Matsuno Y; Morishima Y; Yoh K; Takahashi S; Ogawa K; Hogaboam CM; Hizawa N
    J Immunol; 2014 Feb; 192(4):1707-17. PubMed ID: 24446514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium bovis BCG producing interleukin-18 increases antigen-specific gamma interferon production in mice.
    Biet F; Kremer L; Wolowczuk I; Delacre M; Locht C
    Infect Immun; 2002 Dec; 70(12):6549-57. PubMed ID: 12438324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium avium infection in mice is associated with time-related expression of Th1 and Th2 CD4+ T-lymphocyte response.
    Azouaou N; Petrofsky M; Young LS; Bermudez LE
    Immunology; 1997 Jul; 91(3):414-20. PubMed ID: 9301531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice.
    Moulton RA; Mashruwala MA; Smith AK; Lindsey DR; Wetsel RA; Haviland DL; Hunter RL; Jagannath C
    J Leukoc Biol; 2007 Oct; 82(4):956-67. PubMed ID: 17675563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of IL-12 in immunotherapy and vaccine design in experimental Mycobacterium avium infections.
    Silva RA; Pais TF; Appelberg R
    J Immunol; 1998 Nov; 161(10):5578-85. PubMed ID: 9820535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further studies on the role of IL-12 in Pseudomonas aeruginosa corneal infection.
    Hazlett LD; Huang X; McClellan SA; Barrett RP
    Eye (Lond); 2003 Nov; 17(8):863-71. PubMed ID: 14631390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production.
    Feng CG; Jankovic D; Kullberg M; Cheever A; Scanga CA; Hieny S; Caspar P; Yap GS; Sher A
    J Immunol; 2005 Apr; 174(7):4185-92. PubMed ID: 15778379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of plasmid interleukin-12 with a single DNA vaccine is more effective than Mycobacterium bovis (bacille Calmette-Guèrin) in protecting against systemic Mycobacterim avium infection.
    Martin E; Kamath AT; Briscoe H; Britton WJ
    Immunology; 2003 Jun; 109(2):308-14. PubMed ID: 12757627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo.
    Tahara H; Zeh HJ; Storkus WJ; Pappo I; Watkins SC; Gubler U; Wolf SF; Robbins PD; Lotze MT
    Cancer Res; 1994 Jan; 54(1):182-9. PubMed ID: 7903204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-12p40 overexpression promotes interleukin-12p70 and interleukin-23 formation but does not affect bacille Calmette-Guérin and Mycobacterium tuberculosis clearance.
    Olleros ML; Vesin D; Martinez-Soria E; Allenbach C; Tacchini-Cottier F; Pache JC; Marchal G; Rahman J; Fernández C; Izui S; Garcia I
    Immunology; 2007 Nov; 122(3):350-61. PubMed ID: 17623032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th1 cytokines facilitate CD8-T-cell-mediated early resistance to infection with Mycobacterium tuberculosis in old mice.
    Vesosky B; Flaherty DK; Turner J
    Infect Immun; 2006 Jun; 74(6):3314-24. PubMed ID: 16714559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.